Erik van den Berg, MSc, MBA - Chief Executive Officer

Erik has over fifteen years experience in the pharmaceutical and biotechnology industries. He joined AM-Pharma in September 2007 as Chief Business Officer...

View Profile

Jacques Arend, MD - VP Clinical Development

Jacques has over twenty four years experience in the pharmaceutical industry, where he has held senior positions in medical and clinical development. He joined AM-Pharma in February 2008...

View Profile

Steve Connor, BSc - VP Preclinical Development

Steve has over thirty years management experience and extensive knowledge of the pharmaceutical and biological industries, including the management of R&D and manufacturing operations...

View Profile

Peter Verwayen - VP Finance

Peter has over 35 years experience in finance. He joined AM-Pharma in 2002. Most recently, he worked as Controller for Glaucus Proteomics, a Dutch biotech start-up company...

View Profile

Andrea van Elsas, PhD - VP Research

Andrea has managed various discovery alliances with biotech and academia in the field of Oncology. Previously, he was Proof-of-Concept Team Leader for Schering-Plough's Immune Oncology portfolio...

View Profile